Has Tatsiana Beiko, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,703 in general payments to Tatsiana Beiko, MD across 32 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tatsiana Beiko, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tatsiana Beiko, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tatsiana Beiko, MD

Critical Care Medicine · Charleston, SCNPI 1295037836

Payments from drug & device makers

What this record shows

7 manufacturers reported payments, led by Astrazeneca UK Limited at 44.5% of the total. Reporting peaked in 2019 at $3,204 and has fallen 96.7% since, to $106 in 2025.

$3,703in general payments, 2019–2025

Across 32 payments — averaging $115.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Astrazeneca UK Limited$2K
Vertex$1K
GSK$319
AstraZeneca$235
United Therapeutics Corporation$125
Pulmonx Corporation$106
plus $62 from 1 others

$152,416in research payments, 2019–2025

Across 46 payments — averaging $3313.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Grifols Therapeutics LLC$98K
AstraZeneca$55K

What the payments were for

Travel & lodging$2,02555%
Food & beverage$1,67945%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Astrazeneca UK Limited	14	$1,648
Vertex	10	$1,208
GSK	3	$319
AstraZeneca	2	$235
United Therapeutics Corporation	1	$125
Pulmonx Corporation	1	$106
Advanced Respiratory, Inc	1	$62

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,703 in reported general payments places this provider in the 75th percentile of 93 critical care medicine providers in South Carolina.

See all critical care medicine providers in South Carolina →

Medicare billing

Part B allowed, 2024

$60,327

Medicare patients

Services billed

324

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in Charleston

Charlton StrangeCharleston$205K
Rahul ArgulaCharleston$186K
James CarswellCharleston$159K
Nicholas FoxCharleston$88K
Christopher GilbertCharleston$44K
Gregory SquiresCharleston$14K
John MitchellCharleston$10K
Luca PaolettiCharleston$5K
Jennings NestorCharleston$5K
Stephen SexauerCharleston$2K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →